{"transactions":[{"id":707192,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-17T17:50:44.000Z","date":"2026-07-17","kind":"purchase","planned":false,"acquired":true,"shares":2045,"price":368.25,"value":753071.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":171976,"source":{"system":"sec-edgar","filing":"0001287920-26-000006","document":"wk-form4_1784310641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000006/wk-form4_1784310641.xml","form_type":"4"}},{"id":707191,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-17T17:50:44.000Z","date":"2026-07-17","kind":"purchase","planned":false,"acquired":true,"shares":680,"price":366.41,"value":249158.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby\nundertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":169931,"source":{"system":"sec-edgar","filing":"0001287920-26-000006","document":"wk-form4_1784310641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000006/wk-form4_1784310641.xml","form_type":"4"}},{"id":845173,"issuer":{"id":2967,"kind":"organization","name":"TARGET CORP","symbol":"TGT"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-13T19:11:13.000Z","date":"2026-03-11","kind":"grant","planned":false,"acquired":true,"shares":2682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units pursuant to the Target Corporation 2020 Long-Term Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units."}],"balance_after":12192,"source":{"system":"sec-edgar","filing":"0001287920-26-000004","document":"wk-form4_1773429070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/27419/000128792026000004/wk-form4_1773429070.xml","form_type":"4"}},{"id":862544,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":63818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date."}],"balance_after":63818,"derivative":{"exercise_price":294.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":63818},"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":862543,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1736,"price":284.03,"value":493076.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":169251,"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":862542,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":10527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/2026."}],"balance_after":170987,"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":862541,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":16153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029."}],"balance_after":160460,"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":862540,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:56:45.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6713,"price":294.07,"value":1974091.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":144307,"source":{"system":"sec-edgar","filing":"0001287920-26-000002","document":"wk-form4_1772661402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792026000002/wk-form4_1772661402.xml","form_type":"4"}},{"id":1084859,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-18T17:42:51.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":1050,"price":287.96,"value":302358.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple purchases at prices ranging from $287.72 to $288.14. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":151020,"source":{"system":"sec-edgar","filing":"0001287920-25-000005","document":"wk-form4_1752860565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792025000005/wk-form4_1752860565.xml","form_type":"4"}},{"id":1084858,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-18T17:42:51.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":5116,"price":287.12,"value":1468905.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple purchases at prices ranging from $286.70 to $287.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":149970,"source":{"system":"sec-edgar","filing":"0001287920-25-000005","document":"wk-form4_1752860565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792025000005/wk-form4_1752860565.xml","form_type":"4"}},{"id":1084857,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-18T17:42:51.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":2334,"price":286.07,"value":667687.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple purchases at prices ranging from $285.50 to $286.43. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":144854,"source":{"system":"sec-edgar","filing":"0001287920-25-000005","document":"wk-form4_1752860565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000128792025000005/wk-form4_1752860565.xml","form_type":"4"}},{"id":1207274,"issuer":{"id":2967,"kind":"organization","name":"TARGET CORP","symbol":"TGT"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-14T20:25:50.000Z","date":"2025-03-12","kind":"grant","planned":false,"acquired":true,"shares":2946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units pursuant to the Target Corporation 2020 Long-Term Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units."}],"balance_after":9067,"source":{"system":"sec-edgar","filing":"0000027419-25-000059","document":"wk-form4_1741983944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/27419/000002741925000059/wk-form4_1741983944.xml","form_type":"4"}},{"id":1223447,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-05T21:42:39.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":40429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 40,429 shares, and is exercisable in three annual installments, with two installments of 13,476 shares each and one installment of 13,477 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date."}],"balance_after":40429,"derivative":{"exercise_price":395.5,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":40429},"source":{"system":"sec-edgar","filing":"0001156039-25-000022","document":"wk-form4_1741210952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000022/wk-form4_1741210952.xml","form_type":"4"}},{"id":1223446,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-05T21:42:39.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":15587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/3/2025."}],"balance_after":142520,"source":{"system":"sec-edgar","filing":"0001156039-25-000022","document":"wk-form4_1741210952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000022/wk-form4_1741210952.xml","form_type":"4"}},{"id":1223445,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-05T21:42:39.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":10620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 3,540 shares on 3/3/2026, 3/3/2027 and 3/3/2028."}],"balance_after":126933,"source":{"system":"sec-edgar","filing":"0001156039-25-000022","document":"wk-form4_1741210952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000022/wk-form4_1741210952.xml","form_type":"4"}},{"id":1223444,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-05T21:42:39.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":10396,"price":395.5,"value":4111618.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":116313,"source":{"system":"sec-edgar","filing":"0001156039-25-000022","document":"wk-form4_1741210952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000022/wk-form4_1741210952.xml","form_type":"4"}},{"id":1450061,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T21:02:46.000Z","date":"2024-07-22","kind":"sale","planned":true,"acquired":false,"shares":2250,"price":504.27,"value":1134607.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $504.1 to $504.99. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":126709,"source":{"system":"sec-edgar","filing":"0001156039-24-000109","document":"wk-form4_1721768559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000109/wk-form4_1721768559.xml","form_type":"4"}},{"id":1450060,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T21:02:46.000Z","date":"2024-07-22","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":503.67,"value":503670.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $503.05 to $503.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":128959,"source":{"system":"sec-edgar","filing":"0001156039-24-000109","document":"wk-form4_1721768559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000109/wk-form4_1721768559.xml","form_type":"4"}},{"id":1450059,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T21:02:46.000Z","date":"2024-07-22","kind":"sale","planned":true,"acquired":false,"shares":2250,"price":502.23,"value":1130017.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $501.96 to $502.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":129959,"source":{"system":"sec-edgar","filing":"0001156039-24-000109","document":"wk-form4_1721768559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000109/wk-form4_1721768559.xml","form_type":"4"}},{"id":1450058,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T21:02:46.000Z","date":"2024-07-22","kind":"sale","planned":true,"acquired":false,"shares":6621,"price":501.4,"value":3319769.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $500.83 to $501.79. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":132209,"source":{"system":"sec-edgar","filing":"0001156039-24-000109","document":"wk-form4_1721768559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000109/wk-form4_1721768559.xml","form_type":"4"}},{"id":1450057,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T21:02:46.000Z","date":"2024-07-22","kind":"sale","planned":true,"acquired":false,"shares":20779,"price":500.36,"value":10396980.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $499.82 to $500.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":138830,"source":{"system":"sec-edgar","filing":"0001156039-24-000109","document":"wk-form4_1721768559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000109/wk-form4_1721768559.xml","form_type":"4"}},{"id":1450056,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T21:02:46.000Z","date":"2024-07-22","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":498.5,"value":548350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024."}],"balance_after":159609,"source":{"system":"sec-edgar","filing":"0001156039-24-000109","document":"wk-form4_1721768559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000109/wk-form4_1721768559.xml","form_type":"4"}},{"id":1575957,"issuer":{"id":2967,"kind":"organization","name":"TARGET CORP","symbol":"TGT"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-15T20:17:51.000Z","date":"2024-03-13","kind":"grant","planned":false,"acquired":true,"shares":1873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units pursuant to the Target Corporation 2020 Long-Term Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units."}],"balance_after":5918,"source":{"system":"sec-edgar","filing":"0000027419-24-000085","document":"wk-form4_1710533855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/27419/000002741924000085/wk-form4_1710533855.xml","form_type":"4"}},{"id":1598067,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-05T21:21:08.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":32480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option represents a right to purchase a total of 32,480 shares, and is exercisable in one installment of 10,826 shares and two installments of 10,827 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date."}],"balance_after":32480,"derivative":{"exercise_price":499.11,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":32480},"source":{"system":"sec-edgar","filing":"0001156039-24-000026","document":"wk-form4_1709673632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000026/wk-form4_1709673632.xml","form_type":"4"}},{"id":1598066,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-03-05T21:21:08.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Balance includes 392.27 shares acquired on 3/24/2023, 389.71 shares acquired on 6/23/2023 and 388.21 shares acquired on 9/23/2023 through a dividend reinvestment plan."}],"balance_after":160709,"source":{"system":"sec-edgar","filing":"0001156039-24-000026","document":"wk-form4_1709673632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000026/wk-form4_1709673632.xml","form_type":"4"}},{"id":1598065,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-03-05T21:21:08.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":8415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 2,805 shares each on 3/1/2025,  3/1/2026, and 3/1/2027."}],"balance_after":126192,"source":{"system":"sec-edgar","filing":"0001156039-24-000026","document":"wk-form4_1709673632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000026/wk-form4_1709673632.xml","form_type":"4"}},{"id":1598064,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-03-05T21:21:08.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":19256,"price":499.11,"value":9610862.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":117777,"source":{"system":"sec-edgar","filing":"0001156039-24-000026","document":"wk-form4_1709673632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000026/wk-form4_1709673632.xml","form_type":"4"}},{"id":1960279,"issuer":{"id":2967,"kind":"organization","name":"TARGET CORP","symbol":"TGT"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-11T00:56:42.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":1902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units pursuant to Target Corporation 2020 Long-Term Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units."}],"balance_after":3896,"source":{"system":"sec-edgar","filing":"0001225208-23-003762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/27419/000122520823003762/doc4.xml","form_type":"4"}},{"id":1975014,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-03T21:13:15.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":32380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option represents a right to purchase a total of 32,380 shares, and is exercisable in two installments of 10,793 shares each and one installment of 10,794 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date."}],"balance_after":32380,"derivative":{"exercise_price":469.03,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":32380},"source":{"system":"sec-edgar","filing":"0001156039-23-000024","document":"wf-form4_167787796641640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000024/wf-form4_167787796641640.xml","form_type":"4"}},{"id":1975013,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-03T21:13:15.000Z","date":"2023-03-02","kind":"tax_withholding","acquired":false,"shares":17614,"price":468.78,"value":8257090.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Balance includes 236.42 shares acquired on December 21, 2022 through a dividend reinvestment plan."}],"balance_after":135863,"source":{"system":"sec-edgar","filing":"0001156039-23-000024","document":"wf-form4_167787796641640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000024/wf-form4_167787796641640.xml","form_type":"4"}},{"id":1975012,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-03T21:13:15.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":35875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/2/2023."}],"balance_after":153477,"source":{"system":"sec-edgar","filing":"0001156039-23-000024","document":"wf-form4_167787796641640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000024/wf-form4_167787796641640.xml","form_type":"4"}},{"id":1975011,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-03T21:13:15.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":8422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 2,807 shares each on 3/1/2024 and 3/1/2025 and 2,808 shares on 3/1/2026."}],"balance_after":117602,"source":{"system":"sec-edgar","filing":"0001156039-23-000024","document":"wf-form4_167787796641640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000024/wf-form4_167787796641640.xml","form_type":"4"}},{"id":1975010,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-03T21:13:15.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":2471,"price":469.03,"value":1158973.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":109180,"source":{"system":"sec-edgar","filing":"0001156039-23-000024","document":"wf-form4_167787796641640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000024/wf-form4_167787796641640.xml","form_type":"4"}},{"id":2124632,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-04T21:05:39.000Z","date":"2022-11-04","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Balance includes 252.31 shares acquired on March 25, 2022, 257.62 shares acquired on June 24, 2022 and 266.45 shares acquired on September 23, 2022 through a dividend reinvestment plan."}],"balance_after":111415,"source":{"system":"sec-edgar","filing":"0001156039-22-000094","document":"wf-form4_166759592352354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000094/wf-form4_166759592352354.xml","form_type":"4"}},{"id":2340941,"issuer":{"id":2967,"kind":"organization","name":"TARGET CORP","symbol":"TGT"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-11T00:21:21.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":1432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units pursuant to Target Corporation 2020 Long-Term Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units."}],"balance_after":1949,"source":{"system":"sec-edgar","filing":"0001225208-22-004492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/27419/000122520822004492/doc4.xml","form_type":"4"}},{"id":2355620,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-03T21:41:35.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":32682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option represents a right to purchase a total of 32,682 shares, and is exercisable in three annual installments of 10,894 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date."}],"balance_after":32682,"derivative":{"exercise_price":451.5,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":32682},"source":{"system":"sec-edgar","filing":"0001156039-22-000018","document":"wf-form4_164634367676049.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000018/wf-form4_164634367676049.xml","form_type":"4"}},{"id":2355619,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T21:41:35.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":1645,"price":463.49,"value":762441.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Balance includes 226.50 shares acquired on March 25, 2021, 213.43 shares acquired on June 25, 2021, 214.36 shares acquired on September 24, 2021 and 184.20 shares acquired on December 21, 2021 through a dividend reinvestment plan."}],"balance_after":120639,"source":{"system":"sec-edgar","filing":"0001156039-22-000018","document":"wf-form4_164634367676049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000018/wf-form4_164634367676049.xml","form_type":"4"}},{"id":2355618,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T21:41:35.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":28303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/2022."}],"balance_after":122284,"source":{"system":"sec-edgar","filing":"0001156039-22-000018","document":"wf-form4_164634367676049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000018/wf-form4_164634367676049.xml","form_type":"4"}},{"id":2355617,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T21:41:35.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":8195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 2,731 shares on 3/1/2023, and 2,732 shares each on 3/1/2024 and 3/1/2025."}],"balance_after":93981,"source":{"system":"sec-edgar","filing":"0001156039-22-000018","document":"wf-form4_164634367676049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000018/wf-form4_164634367676049.xml","form_type":"4"}},{"id":2355616,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T21:41:35.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":15352,"price":451.5,"value":6931428.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":85786,"source":{"system":"sec-edgar","filing":"0001156039-22-000018","document":"wf-form4_164634367676049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000018/wf-form4_164634367676049.xml","form_type":"4"}},{"id":2560520,"issuer":{"id":2967,"kind":"organization","name":"TARGET CORP","symbol":"TGT"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-09-24T20:32:10.000Z","date":"2021-09-23","kind":"grant","acquired":true,"shares":514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units pursuant to the Target Corporation 2020 Long-Term Incentive Plan."}],"balance_after":514,"source":{"system":"sec-edgar","filing":"0001225208-21-012556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/27419/000122520821012556/doc4.xml","form_type":"4"}},{"id":2761973,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2021-04-02T16:41:45.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":169.785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 17.692 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":11743.19,"derivative":{"exercise_price":161.97,"underlying":"Common Stock","underlying_shares":169.785},"source":{"system":"sec-edgar","filing":"0001062993-21-003333","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299321003333/form4.xml","form_type":"4"}},{"id":2814822,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-03T21:36:56.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":43501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option represents a right to purchase a total of 43,501 shares, and is exercisable in three annual installments, with two installments of 14,500 shares each and one installment of 14,501 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date."}],"balance_after":43501,"derivative":{"exercise_price":311.48,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":43501},"source":{"system":"sec-edgar","filing":"0001156039-21-000032","document":"wf-form4_161480737555662.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000032/wf-form4_161480737555662.xml","form_type":"4"}},{"id":2814821,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:36:56.000Z","date":"2021-03-02","kind":"tax_withholding","acquired":false,"shares":1644,"price":311.66,"value":512369.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Balance includes 78.8 shares acquired on December 22, 2020 through a dividend reinvestment plan."}],"balance_after":100300,"source":{"system":"sec-edgar","filing":"0001156039-21-000032","document":"wf-form4_161480737555662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000032/wf-form4_161480737555662.xml","form_type":"4"}},{"id":2814820,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:36:56.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":73240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/2021."}],"balance_after":101944,"source":{"system":"sec-edgar","filing":"0001156039-21-000032","document":"wf-form4_161480737555662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000032/wf-form4_161480737555662.xml","form_type":"4"}},{"id":2814819,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:36:56.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 3,531 shares on 3/1/2022, and 3,532 shares each on 3/1/2023 and 3/1/2024."}],"balance_after":28704,"source":{"system":"sec-edgar","filing":"0001156039-21-000032","document":"wf-form4_161480737555662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000032/wf-form4_161480737555662.xml","form_type":"4"}},{"id":2814818,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:36:56.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":35564,"price":311.48,"value":11077474.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":18109,"source":{"system":"sec-edgar","filing":"0001156039-21-000032","document":"wf-form4_161480737555662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000032/wf-form4_161480737555662.xml","form_type":"4"}},{"id":2921717,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2021-01-05T21:49:31.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":179.891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 20.577 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":11555.713,"derivative":{"exercise_price":152.87,"underlying":"Common Stock","underlying_shares":179.891},"source":{"system":"sec-edgar","filing":"0001062993-21-000107","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299321000107/form4.xml","form_type":"4"}},{"id":2961139,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-02T21:32:31.000Z","date":"2020-12-01","kind":"tax_withholding","acquired":false,"shares":14764,"price":313.9,"value":4634419.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes 28.73 shares acquired on March 27, 2020, 25.06 shares acquired on June 25, 2020 and 25.98 shares acquired on September 25, 2020 through a dividend reinvestment plan."}],"balance_after":53594,"source":{"system":"sec-edgar","filing":"0001156039-20-000100","document":"wf-form4_160694473484383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000100/wf-form4_160694473484383.xml","form_type":"4"}},{"id":3016684,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2020-10-02T20:36:29.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":202.563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 19.308 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":11355.245,"derivative":{"exercise_price":135.76,"underlying":"Common Stock","underlying_shares":202.563},"source":{"system":"sec-edgar","filing":"0001062993-20-004774","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299320004774/form4.xml","form_type":"4"}},{"id":3092579,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2020-07-02T20:50:37.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":232.303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":11133.374,"derivative":{"exercise_price":118.38,"underlying":"Common Stock","underlying_shares":232.303},"source":{"system":"sec-edgar","filing":"0000911916-20-000158","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191620000158/edgar.xml","form_type":"4"}},{"id":3152987,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-12T20:32:05.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":1077.229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods."}],"balance_after":9441.11,"derivative":{"underlying":"Common Stock","underlying_shares":1077.229},"source":{"system":"sec-edgar","filing":"0000911916-20-000100","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191620000100/edgar.xml","form_type":"4"}},{"id":3152986,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2020-05-12T20:32:05.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 20.103 phantom stock units accrued on April 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":10901.071,"derivative":{"exercise_price":120.68,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000911916-20-000100","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191620000100/edgar.xml","form_type":"4"}},{"id":3186954,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2020-04-02T21:17:32.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":277.722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 15.93 phantom stock units accrued on January 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":10380.968,"derivative":{"exercise_price":99.02,"underlying":"Common Stock","underlying_shares":277.722},"source":{"system":"sec-edgar","filing":"0000911916-20-000084","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191620000084/edgar.xml","form_type":"4"}},{"id":3228204,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-04T21:38:21.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":58809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 58,809 shares, and is exercisable in three annual installments of 19,603 shares each, beginning on 3/2/2021, which is the one-year anniversary of the option grant date."}],"balance_after":58809,"derivative":{"exercise_price":271.27,"expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":58809},"source":{"system":"sec-edgar","filing":"0001127602-20-009432","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009432/form4.xml","form_type":"4"}},{"id":3228203,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-04T21:38:21.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":33102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 12/1/2020."}],"balance_after":68277.78,"source":{"system":"sec-edgar","filing":"0001127602-20-009432","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009432/form4.xml","form_type":"4"}},{"id":3228202,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-04T21:38:21.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":11060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 3,686 shares on 3/2/2021, and 3,687 shares each on 3/2/2022 and 3/2/2023."}],"balance_after":35175.78,"source":{"system":"sec-edgar","filing":"0001127602-20-009432","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009432/form4.xml","form_type":"4"}},{"id":3228201,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-04T21:38:21.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":2440,"price":271.27,"value":661898.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":24115.78,"source":{"system":"sec-edgar","filing":"0001127602-20-009432","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009432/form4.xml","form_type":"4"}},{"id":3296825,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-31T11:01:29.000Z","date":"2020-01-30","kind":"purchase","acquired":true,"shares":2000,"price":264.22,"value":528440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $264.06 to $264.36. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff,\nthe issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Balance includes 6.78 shares acquired through a dividend reinvestment plan."}],"balance_after":26555.78,"source":{"system":"sec-edgar","filing":"0001127602-20-002815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220002815/form4.xml","form_type":"4"}},{"id":3296824,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-31T11:01:29.000Z","date":"2020-01-30","kind":"purchase","acquired":true,"shares":5600,"price":263.52,"value":1475712.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $262.93 to $263.88. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff,\nthe issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24555.78,"source":{"system":"sec-edgar","filing":"0001127602-20-002815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220002815/form4.xml","form_type":"4"}},{"id":3323786,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2020-01-03T21:41:55.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":184.564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 17.231 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":10087.316,"derivative":{"exercise_price":149,"underlying":"Common Stock","underlying_shares":184.564},"source":{"system":"sec-edgar","filing":"0000911916-20-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191620000007/edgar.xml","form_type":"4"}},{"id":3401352,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2019-10-02T20:34:52.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":174.466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 16.862 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":9885.521,"derivative":{"exercise_price":136.13,"underlying":"Common Stock","underlying_shares":174.466},"source":{"system":"sec-edgar","filing":"0000911916-19-000170","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191619000170/edgar.xml","form_type":"4"}},{"id":3471742,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2019-07-02T20:17:34.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":204.161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":9694.193,"derivative":{"exercise_price":116.33,"underlying":"Common Stock","underlying_shares":204.161},"source":{"system":"sec-edgar","filing":"0000911916-19-000146","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191619000146/edgar.xml","form_type":"4"}},{"id":3527860,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-14T21:23:13.000Z","date":"2019-05-10","kind":"grant","acquired":true,"shares":1078.122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods."}],"balance_after":8363.881,"derivative":{"underlying":"Common Stock","underlying_shares":1078.122},"source":{"system":"sec-edgar","filing":"0000911916-19-000110","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191619000110/edgar.xml","form_type":"4"}},{"id":3527859,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2019-05-14T21:23:13.000Z","date":"2019-05-10","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 17.300 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":9490.032,"derivative":{"exercise_price":120.58,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000911916-19-000110","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191619000110/edgar.xml","form_type":"4"}},{"id":3569266,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2019-04-02T23:01:25.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":186.67,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 18.836 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8972.732,"derivative":{"exercise_price":127.23,"underlying":"Common Stock","underlying_shares":186.67},"source":{"system":"sec-edgar","filing":"0000911916-19-000098","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191619000098/edgar.xml","form_type":"4"}},{"id":3613899,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-05T21:06:48.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":41820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option represents a right to purchase a total of 41,820 shares, and is exercisable in three annual installments of 13,940 shares each, beginning on 3/1/2020, which is the one-year anniversary of the option grant date."}],"balance_after":41820,"derivative":{"exercise_price":307.68,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":41820},"source":{"system":"sec-edgar","filing":"0001127602-19-009896","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219009896/form4.xml","form_type":"4"}},{"id":3613898,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-05T21:06:48.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":9060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 3,020 shares each on 3/1/2020, 3/1/2021 and 3/1/2022."}],"balance_after":18949,"source":{"system":"sec-edgar","filing":"0001127602-19-009896","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219009896/form4.xml","form_type":"4"}},{"id":3613897,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-05T21:06:48.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":1155,"price":307.68,"value":355370.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":9889,"source":{"system":"sec-edgar","filing":"0001127602-19-009896","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219009896/form4.xml","form_type":"4"}},{"id":3672440,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-06T21:53:16.000Z","date":"2019-02-05","kind":"purchase","acquired":true,"shares":2095,"price":119.326,"value":249987.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the purchase of 2,095 shares in multiple transactions ranging in price from $119.19 to $119.49 per share, resulting in a weighted average purchase price of $119.326. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range."}],"balance_after":2095,"source":{"system":"sec-edgar","filing":"0000911916-19-000024","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191619000024/edgar.xml","form_type":"4"}},{"id":3709590,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2019-01-03T21:16:55.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":229.668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 17.437 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8767.226,"derivative":{"exercise_price":103.41,"underlying":"Common Stock","underlying_shares":229.668},"source":{"system":"sec-edgar","filing":"0000911916-19-000003","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191619000003/edgar.xml","form_type":"4"}},{"id":3802271,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2018-10-02T19:50:59.000Z","date":"2018-09-30","kind":"grant","acquired":true,"shares":181.783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 15.468 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8520.121,"derivative":{"exercise_price":130.65,"underlying":"Common Stock","underlying_shares":181.783},"source":{"system":"sec-edgar","filing":"0000911916-18-000177","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191618000177/edgar.xml","form_type":"4"}},{"id":3875870,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2018-07-03T20:05:58.000Z","date":"2018-06-30","kind":"grant","acquired":true,"shares":211.393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."}],"balance_after":8322.87,"derivative":{"exercise_price":112.35,"underlying":"Common Stock","underlying_shares":211.393},"source":{"system":"sec-edgar","filing":"0000911916-18-000133","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191618000133/edgar.xml","form_type":"4"}},{"id":3928613,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-17T18:13:02.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":1143.159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods."}],"balance_after":7285.759,"derivative":{"underlying":"Common Stock","underlying_shares":1143.159},"source":{"system":"sec-edgar","filing":"0000911916-18-000121","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191618000121/edgar.xml","form_type":"4"}},{"id":3928612,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2018-05-17T18:13:02.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director (\"Annual Deferred Share Units\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director (\"Annual Deferred Share Units\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 15.229 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8111.477,"derivative":{"exercise_price":113.72,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000911916-18-000121","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191618000121/edgar.xml","form_type":"4"}},{"id":3973667,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2018-04-03T19:09:02.000Z","date":"2018-03-31","kind":"grant","acquired":true,"shares":218.672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 13.462 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":7596.248,"derivative":{"exercise_price":108.61,"underlying":"Common Stock","underlying_shares":218.672},"source":{"system":"sec-edgar","filing":"0000911916-18-000104","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191618000104/edgar.xml","form_type":"4"}},{"id":4016013,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-05T21:38:58.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":46554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option represents a right to purchase a total of 46,554 shares, and is exercisable in six semi-annual installments of 7,759 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date."}],"balance_after":46554,"derivative":{"exercise_price":232.04,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":46554},"source":{"system":"sec-edgar","filing":"0001127602-18-010085","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010085/form4.xml","form_type":"4"}},{"id":4016012,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-05T21:38:58.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":11044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units. Restrictions lapse as follows: 3,681 shares each on 3/1/2019 and 3/1/2020, and 3,682 on 3/1/2021."}],"balance_after":11044,"source":{"system":"sec-edgar","filing":"0001127602-18-010085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010085/form4.xml","form_type":"4"}},{"id":4112893,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2018-01-03T18:28:43.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":195.812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 13.973 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":7364.114,"derivative":{"exercise_price":121.29,"underlying":"Common Stock","underlying_shares":195.812},"source":{"system":"sec-edgar","filing":"0000911916-18-000013","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191618000013/edgar.xml","form_type":"4"}},{"id":4118630,"issuer":{"id":3042,"kind":"organization","name":"XCEL ENERGY INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-01-02T22:14:13.000Z","date":"2017-12-28","kind":"grant","acquired":true,"shares":690.377,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Of the 690.377 stock equivalent units, 575.314 were granted at a price of $47.80 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 115.063 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Of the 690.377 stock equivalent units, 575.314 were granted at a price of $47.80 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 115.063 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 348.905 stock equivalent units acquired pursuant to the reinvestment of dividend equivalents during the current quarter."}],"balance_after":49473.053,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":690.377},"source":{"system":"sec-edgar","filing":"0001140361-18-000218","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72903/000114036118000218/doc1.xml","form_type":"4"}},{"id":4195219,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-10-03T12:50:10.000Z","date":"2017-09-30","kind":"grant","acquired":true,"shares":204.266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 13.391 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":7154.329,"derivative":{"exercise_price":116.27,"underlying":"Common Stock","underlying_shares":204.266},"source":{"system":"sec-edgar","filing":"0000911916-17-000234","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191617000234/edgar.xml","form_type":"4"}},{"id":4199679,"issuer":{"id":3042,"kind":"organization","name":"XCEL ENERGY INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-09-29T20:33:58.000Z","date":"2017-09-28","kind":"grant","acquired":true,"shares":701.531,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Of the 701.531 stock equivalent units, 584.609 were granted at a price of $47.04 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 116.922 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Of the 701.531 stock equivalent units, 584.609 were granted at a price of $47.04 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 116.922 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 360.385 stock equivalent units acquired pursuant to the reinvestment of dividend equivalents during the current quarter."}],"balance_after":48433.771,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":701.531},"source":{"system":"sec-edgar","filing":"0001140361-17-036958","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72903/000114036117036958/doc1.xml","form_type":"4"}},{"id":4264993,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-07-05T19:50:47.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":184.954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."}],"balance_after":6936.672,"derivative":{"exercise_price":128.41,"underlying":"Common Stock","underlying_shares":184.954},"source":{"system":"sec-edgar","filing":"0000911916-17-000210","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191617000210/edgar.xml","form_type":"4"}},{"id":4269842,"issuer":{"id":3042,"kind":"organization","name":"XCEL ENERGY INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-06-30T14:21:45.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":701.978,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Of the 701.978 stock equivalent units, 584.982 were granted at a price of $47.01 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 116.996 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Of the 701.978 stock equivalent units, 584.982 were granted at a price of $47.01 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 116.996 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."}],"balance_after":47371.855,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":701.978},"source":{"system":"sec-edgar","filing":"0001140361-17-026749","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72903/000114036117026749/doc1.xml","form_type":"4"}},{"id":4312968,"issuer":{"id":3042,"kind":"organization","name":"XCEL ENERGY INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-05-19T20:45:04.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":3069.502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock. Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock. Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock. Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 341.691 shares of stock equivalent units acquired pursuant to reinvestment of stock equivalent unit dividends."}],"balance_after":46669.877,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3069.502},"source":{"system":"sec-edgar","filing":"0001140361-17-021578","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72903/000114036117021578/doc1.xml","form_type":"4"}},{"id":4318634,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-16T18:15:21.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":1067.85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods."}],"balance_after":6142.6,"derivative":{"underlying":"Common Stock","underlying_shares":1067.85},"source":{"system":"sec-edgar","filing":"0000911916-17-000176","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191617000176/edgar.xml","form_type":"4"}},{"id":4318633,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-05-16T18:15:21.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director (\"Annual Deferred Share Units\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director (\"Annual Deferred Share Units\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 12.639 phantom stock units accrued on April 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":6751.718,"derivative":{"exercise_price":121.74,"underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000911916-17-000176","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191617000176/edgar.xml","form_type":"4"}},{"id":4361841,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-04-04T19:08:58.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":195.489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 11.936 phantom stock units accrued on January 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":6239.079,"derivative":{"exercise_price":121.49,"underlying":"Common Stock","underlying_shares":195.489},"source":{"system":"sec-edgar","filing":"0000911916-17-000145","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191617000145/edgar.xml","form_type":"4"}},{"id":4369097,"issuer":{"id":3042,"kind":"organization","name":"XCEL ENERGY INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-03-30T16:06:03.000Z","date":"2017-03-28","kind":"grant","acquired":true,"shares":737.101,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Of the 737.101 stock equivalent units, 614.25 were granted at a price of $44.77 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 122.85 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Of the 737.101 stock equivalent units, 614.25 were granted at a price of $44.77 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 122.85 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 343.970 stock equivalent units acquired pursuant to the reinvestment of dividend equivalents during the current quarter."}],"balance_after":43258.684,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":737.101},"source":{"system":"sec-edgar","filing":"0001140361-17-013884","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72903/000114036117013884/doc1.xml","form_type":"4"}},{"id":4378474,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-03-20T20:18:00.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan will vest one (1) year from the March 16, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":80000,"derivative":{"exercise_price":1.38,"exercise_date":"2018-03-16","expiration_date":"2027-03-16","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-17-021710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919117021710/doc4.xml","form_type":"4"}},{"id":4503367,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-01-04T20:45:45.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":229.713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 11.016 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":6031.654,"derivative":{"exercise_price":103.39,"underlying":"Common Stock","underlying_shares":229.713},"source":{"system":"sec-edgar","filing":"0000911916-17-000008","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191617000008/edgar.xml","form_type":"4"}},{"id":4510161,"issuer":{"id":3042,"kind":"organization","name":"XCEL ENERGY INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-12-30T20:26:17.000Z","date":"2016-12-28","kind":"grant","acquired":true,"shares":810.214,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Of the 810.214 stock equivalent units, 675.178 were granted at a price of $40.73 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 135.036 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Of the 810.214 stock equivalent units, 675.178 were granted at a price of $40.73 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 135.036 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 339.602 stock equivalent units acquired pursuant to the reinvestment of dividend equivalents during the current quarter."}],"balance_after":42177.613,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":810.214},"source":{"system":"sec-edgar","filing":"0001140361-16-091186","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72903/000114036116091186/doc1.xml","form_type":"4"}},{"id":4587538,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2016-10-04T20:21:12.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":183.582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (\"Company\") Deferred Compensation Plan for Non-Employee Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Conversion or Exercise Price of Derivative Security is 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 10.013 phantom stock units accrued on July 29, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":5790.925,"derivative":{"exercise_price":129.37,"underlying":"Common Stock","underlying_shares":183.582},"source":{"system":"sec-edgar","filing":"0000911916-16-000666","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000091191616000666/edgar.xml","form_type":"4"}},{"id":4592437,"issuer":{"id":3042,"kind":"organization","name":"XCEL ENERGY INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-09-30T20:53:48.000Z","date":"2016-09-28","kind":"grant","acquired":true,"shares":754.995,"price":42.37,"value":31989.13815,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"Of the 754.995 stock equivalent units, 629.162 were granted at a price of $42.37 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 125.833 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Of the 754.995 stock equivalent units, 629.162 were granted at a price of $42.37 per unit in connection with the reporting person's election to defer receipt of quarterly cash director retainers, and 125.833 were granted at no cost to the reporting person as a 20% premium on the amount of such retainer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each stock equivalent unit is the economic equivalent of one share of common stock.  Whole stock equivalent units are payable in shares of common stock following termination of a reporting person's service as a director; fractional units are payable at such time in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 304.731 shares of stock equivalent units acquired pursuant to reinvestment of stock equivalent unit dividends."}],"balance_after":41027.797,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":754.995},"source":{"system":"sec-edgar","filing":"0001140361-16-081242","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72903/000114036116081242/doc1.xml","form_type":"4"}},{"id":4598293,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-21T20:21:54.000Z","date":"2016-09-20","kind":"purchase","acquired":true,"shares":100000,"price":1.4485,"value":144850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.45, inclusive. The reporting person undertakes to provide Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001209191-16-142271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919116142271/doc4.xml","form_type":"4"}},{"id":170091,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2014-09-25T20:53:27.000Z","date":"2014-09-23","kind":"grant","acquired":true,"shares":657.185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividend equivalents paid on outstanding restricted stock units.  The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan."}],"balance_after":184731.6713,"source":{"system":"sec-edgar","filing":"0001209191-14-059795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919114059795/doc4.xml","form_type":"4"}},{"id":172716,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2014-06-27T20:41:19.000Z","date":"2014-06-25","kind":"grant","acquired":true,"shares":687.972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividend equivalents paid on outstanding restricted stock units.  The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest."}],"balance_after":183739.2603,"source":{"system":"sec-edgar","filing":"0001209191-14-044163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919114044163/doc4.xml","form_type":"4"}},{"id":174971,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2014-03-26T21:07:35.000Z","date":"2014-03-25","kind":"grant","acquired":true,"shares":519.746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividend equivalents paid on outstanding restricted stock units.  The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest."}],"balance_after":183051.2883,"source":{"system":"sec-edgar","filing":"0001209191-14-023213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919114023213/doc4.xml","form_type":"4"}},{"id":175802,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CEO, UnitedHealthcare"}}],"security":"Stock Appreciation Rights","published_at":"2014-03-03T22:05:42.000Z","date":"2014-02-27","kind":"exercise","acquired":false,"shares":19006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights vested at a rate of 25% annually on February 9 from the years 2011 through 2014."}],"balance_after":0,"derivative":{"exercise_price":33,"expiration_date":"2020-02-09","underlying":"Common Stock","underlying_shares":19006},"source":{"system":"sec-edgar","filing":"0001209191-14-015913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919114015913/doc4.xml","form_type":"4"}},{"id":175801,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":12574,"kind":"person","name":"BOUDREAUX GAIL","position":1,"cik":"0001287920","reported_name":"BOUDREAUX GAIL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CEO, UnitedHealthcare"}}],"security":"Common Stock","published_at":"2014-03-03T22:05:42.000Z","date":"2014-02-28","kind":"sale","acquired":false,"shares":3678,"price":76.13,"value":280006.14,"ownership":{"direct":true},"balance_after":182531.5423,"source":{"system":"sec-edgar","filing":"0001209191-14-015913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919114015913/doc4.xml","form_type":"4"}}],"next_cursor":"2014-03-03T22:05:42.000000Z,175801"}